Increase of macrolide resistance among Streptococcus pyogenes pharyngitis driven by a mef(A)-msr(D)/emm2-ST55 lineage in Portugal (2014-2019).

Antimicrob Agents Chemother · 2025 · PMC12587576 · PMID 41071123

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a decreasing trendno p-value reported

In line with pharyngeal isolates collected nationwide during 2007–2013 and with invasive isolates throughout the 2010s ( 7 , 11 ), overall macrolide resistance among the isolates recovered at ULSRL during 2014–2019 was low (4%), presenting a decreasing trend between 2014 and 2016.

also in 47,180 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.

Increase of macrolide resistance among &lt;i&gt;Streptococcus pyogenes&lt;/i&gt; pharyngitis driven by a &lt;i&gt;mef&lt;/i&gt;(A)-&lt;i&gt;msr&lt;/i&gt;(D)/&lt;i&gt;emm&lt;/i&gt;2-ST55 lineage in Portugal (2014-2019).

The sentences

Increase of macrolide resistance among <i>Streptococcus pyogenes</i> pharyngitis driven by a <i>mef</i>(A)-<i>msr</i>(D)/<i>emm</i>2-ST55 lineage in Portugal (2014-2019).